nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—systemic scleroderma—primary biliary cirrhosis	0.162	0.387	CtDrD
Methotrexate—systemic lupus erythematosus—primary biliary cirrhosis	0.132	0.315	CtDrD
Methotrexate—rheumatoid arthritis—primary biliary cirrhosis	0.124	0.298	CtDrD
Methotrexate—ABCC2—primary biliary cirrhosis	0.101	0.441	CbGaD
Methotrexate—ABCG2—primary biliary cirrhosis	0.0889	0.39	CbGaD
Methotrexate—ABCC4—Ursodeoxycholic acid—primary biliary cirrhosis	0.0679	0.332	CbGbCtD
Methotrexate—SLCO1A2—Ursodeoxycholic acid—primary biliary cirrhosis	0.0487	0.238	CbGbCtD
Methotrexate—ABCC2—Ursodeoxycholic acid—primary biliary cirrhosis	0.0404	0.198	CbGbCtD
Methotrexate—ALB—primary biliary cirrhosis	0.0388	0.17	CbGaD
Methotrexate—ABCC1—Colchicine—primary biliary cirrhosis	0.0382	0.187	CbGbCtD
Methotrexate—ABCB1—Colchicine—primary biliary cirrhosis	0.00921	0.0451	CbGbCtD
Methotrexate—ABCC2—bile canaliculus—primary biliary cirrhosis	0.00875	0.277	CbGeAlD
Methotrexate—ABCC3—bile duct—primary biliary cirrhosis	0.00342	0.108	CbGeAlD
Methotrexate—ABCC2—bile duct—primary biliary cirrhosis	0.00273	0.0864	CbGeAlD
Methotrexate—ABCC2—bile—primary biliary cirrhosis	0.0021	0.0664	CbGeAlD
Methotrexate—FOLR1—epithelium—primary biliary cirrhosis	0.0012	0.038	CbGeAlD
Methotrexate—Retinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.0147	CcSEcCtD
Methotrexate—Pericardial effusion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00089	0.0128	CcSEcCtD
Methotrexate—Pericardial effusion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00089	0.0128	CcSEcCtD
Methotrexate—Pericarditis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000844	0.0121	CcSEcCtD
Methotrexate—Pericarditis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000844	0.0121	CcSEcCtD
Methotrexate—Pulmonary fibrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00083	0.0119	CcSEcCtD
Methotrexate—Pulmonary fibrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00083	0.0119	CcSEcCtD
Methotrexate—Appetite absent—Colchicine—primary biliary cirrhosis	0.000817	0.0117	CcSEcCtD
Methotrexate—Lung infiltration—Ursodeoxycholic acid—primary biliary cirrhosis	0.000778	0.0112	CcSEcCtD
Methotrexate—Lung infiltration—Chenodeoxycholic acid—primary biliary cirrhosis	0.000778	0.0112	CcSEcCtD
Methotrexate—GGH—smooth muscle tissue—primary biliary cirrhosis	0.000769	0.0243	CbGeAlD
Methotrexate—Interstitial pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000755	0.0108	CcSEcCtD
Methotrexate—Interstitial pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000755	0.0108	CcSEcCtD
Methotrexate—AOX1—gall bladder—primary biliary cirrhosis	0.000746	0.0236	CbGeAlD
Methotrexate—ABCC3—gall bladder—primary biliary cirrhosis	0.00073	0.0231	CbGeAlD
Methotrexate—ATIC—epithelium—primary biliary cirrhosis	0.000678	0.0215	CbGeAlD
Methotrexate—ATIC—smooth muscle tissue—primary biliary cirrhosis	0.000654	0.0207	CbGeAlD
Methotrexate—ABCC11—liver—primary biliary cirrhosis	0.000652	0.0206	CbGeAlD
Methotrexate—Leucovorin—ABCC2—primary biliary cirrhosis	0.000633	0.452	CrCbGaD
Methotrexate—ALB—gall bladder—primary biliary cirrhosis	0.000622	0.0197	CbGeAlD
Methotrexate—Polyp—Chenodeoxycholic acid—primary biliary cirrhosis	0.0006	0.0086	CcSEcCtD
Methotrexate—Polyp—Ursodeoxycholic acid—primary biliary cirrhosis	0.0006	0.0086	CcSEcCtD
Methotrexate—SLC19A1—liver—primary biliary cirrhosis	0.000597	0.0189	CbGeAlD
Methotrexate—Psoriasis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000581	0.00833	CcSEcCtD
Methotrexate—Psoriasis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000581	0.00833	CcSEcCtD
Methotrexate—Cyst—Chenodeoxycholic acid—primary biliary cirrhosis	0.000546	0.00783	CcSEcCtD
Methotrexate—Cyst—Ursodeoxycholic acid—primary biliary cirrhosis	0.000546	0.00783	CcSEcCtD
Methotrexate—Interstitial lung disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000516	0.00739	CcSEcCtD
Methotrexate—Lung disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000516	0.00739	CcSEcCtD
Methotrexate—Interstitial lung disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000516	0.00739	CcSEcCtD
Methotrexate—Lung disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000516	0.00739	CcSEcCtD
Methotrexate—Pleural effusion—Ursodeoxycholic acid—primary biliary cirrhosis	0.000477	0.00683	CcSEcCtD
Methotrexate—Pleural effusion—Chenodeoxycholic acid—primary biliary cirrhosis	0.000477	0.00683	CcSEcCtD
Methotrexate—Skin ulcer—Ursodeoxycholic acid—primary biliary cirrhosis	0.000469	0.00672	CcSEcCtD
Methotrexate—Skin ulcer—Chenodeoxycholic acid—primary biliary cirrhosis	0.000469	0.00672	CcSEcCtD
Methotrexate—SLC46A1—liver—primary biliary cirrhosis	0.00046	0.0145	CbGeAlD
Methotrexate—GGH—liver—primary biliary cirrhosis	0.000452	0.0143	CbGeAlD
Methotrexate—TYMS—smooth muscle tissue—primary biliary cirrhosis	0.000443	0.014	CbGeAlD
Methotrexate—Oliguria—Colchicine—primary biliary cirrhosis	0.000441	0.00632	CcSEcCtD
Methotrexate—PGD—smooth muscle tissue—primary biliary cirrhosis	0.000422	0.0133	CbGeAlD
Methotrexate—SLC16A1—epithelium—primary biliary cirrhosis	0.000409	0.0129	CbGeAlD
Methotrexate—Tetrahydrofolic acid—ABCC2—primary biliary cirrhosis	0.000408	0.291	CrCbGaD
Methotrexate—Bone disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000404	0.00579	CcSEcCtD
Methotrexate—Skin discolouration—Chenodeoxycholic acid—primary biliary cirrhosis	0.000404	0.00579	CcSEcCtD
Methotrexate—Skin discolouration—Ursodeoxycholic acid—primary biliary cirrhosis	0.000404	0.00579	CcSEcCtD
Methotrexate—Bone disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000404	0.00579	CcSEcCtD
Methotrexate—SLCO4C1—liver—primary biliary cirrhosis	0.000401	0.0127	CbGeAlD
Methotrexate—FPGS—liver—primary biliary cirrhosis	0.000398	0.0126	CbGeAlD
Methotrexate—Herpes simplex—Ursodeoxycholic acid—primary biliary cirrhosis	0.000396	0.00568	CcSEcCtD
Methotrexate—Herpes simplex—Chenodeoxycholic acid—primary biliary cirrhosis	0.000396	0.00568	CcSEcCtD
Methotrexate—SLCO1B3—liver—primary biliary cirrhosis	0.00039	0.0123	CbGeAlD
Methotrexate—Hepatic enzyme increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000386	0.00553	CcSEcCtD
Methotrexate—Hepatic enzyme increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000386	0.00553	CcSEcCtD
Methotrexate—ATIC—liver—primary biliary cirrhosis	0.000385	0.0122	CbGeAlD
Methotrexate—Aplastic anaemia—Colchicine—primary biliary cirrhosis	0.000381	0.00547	CcSEcCtD
Methotrexate—Bladder pain—Colchicine—primary biliary cirrhosis	0.000367	0.00527	CcSEcCtD
Methotrexate—Vaginal inflammation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000365	0.00523	CcSEcCtD
Methotrexate—Vaginal inflammation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000365	0.00523	CcSEcCtD
Methotrexate—Folic Acid—ABCG2—primary biliary cirrhosis	0.00036	0.257	CrCbGaD
Methotrexate—Melaena—Ursodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00511	CcSEcCtD
Methotrexate—Cystitis noninfective—Chenodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00511	CcSEcCtD
Methotrexate—Cystitis noninfective—Ursodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00511	CcSEcCtD
Methotrexate—Melaena—Chenodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00511	CcSEcCtD
Methotrexate—Cystitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000352	0.00505	CcSEcCtD
Methotrexate—Cystitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000352	0.00505	CcSEcCtD
Methotrexate—Vaginal infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000345	0.00494	CcSEcCtD
Methotrexate—Vaginal infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000345	0.00494	CcSEcCtD
Methotrexate—Ecchymosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00033	0.00473	CcSEcCtD
Methotrexate—Neoplasm—Ursodeoxycholic acid—primary biliary cirrhosis	0.00033	0.00473	CcSEcCtD
Methotrexate—Bladder pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00033	0.00473	CcSEcCtD
Methotrexate—Neoplasm—Chenodeoxycholic acid—primary biliary cirrhosis	0.00033	0.00473	CcSEcCtD
Methotrexate—Ecchymosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00033	0.00473	CcSEcCtD
Methotrexate—Bladder pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00033	0.00473	CcSEcCtD
Methotrexate—Lymphadenopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000311	0.00445	CcSEcCtD
Methotrexate—Lymphadenopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000311	0.00445	CcSEcCtD
Methotrexate—SLC22A11—liver—primary biliary cirrhosis	0.000311	0.00982	CbGeAlD
Methotrexate—SLC22A7—liver—primary biliary cirrhosis	0.000303	0.00959	CbGeAlD
Methotrexate—Photosensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000302	0.00433	CcSEcCtD
Methotrexate—Photosensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000302	0.00433	CcSEcCtD
Methotrexate—MTHFR—liver—primary biliary cirrhosis	0.000286	0.00904	CbGeAlD
Methotrexate—SLCO3A1—liver—primary biliary cirrhosis	0.000281	0.00889	CbGeAlD
Methotrexate—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.00027	0.00388	CcSEcCtD
Methotrexate—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.00027	0.00388	CcSEcCtD
Methotrexate—TYMS—liver—primary biliary cirrhosis	0.000261	0.00825	CbGeAlD
Methotrexate—DHFR—liver—primary biliary cirrhosis	0.000258	0.00817	CbGeAlD
Methotrexate—PGD—liver—primary biliary cirrhosis	0.000248	0.00785	CbGeAlD
Methotrexate—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00351	CcSEcCtD
Methotrexate—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00351	CcSEcCtD
Methotrexate—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.000244	0.0035	CcSEcCtD
Methotrexate—Pancytopenia—Colchicine—primary biliary cirrhosis	0.000242	0.00347	CcSEcCtD
Methotrexate—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000239	0.00343	CcSEcCtD
Methotrexate—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000239	0.00343	CcSEcCtD
Methotrexate—Neutropenia—Colchicine—primary biliary cirrhosis	0.000238	0.00342	CcSEcCtD
Methotrexate—SLC16A1—liver—primary biliary cirrhosis	0.000232	0.00733	CbGeAlD
Methotrexate—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.000229	0.00328	CcSEcCtD
Methotrexate—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.000229	0.00328	CcSEcCtD
Methotrexate—SLCO1B1—liver—primary biliary cirrhosis	0.000225	0.00713	CbGeAlD
Methotrexate—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000225	0.00322	CcSEcCtD
Methotrexate—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000225	0.00322	CcSEcCtD
Methotrexate—Stomatitis—Colchicine—primary biliary cirrhosis	0.000222	0.00318	CcSEcCtD
Methotrexate—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00315	CcSEcCtD
Methotrexate—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00315	CcSEcCtD
Methotrexate—AOX1—liver—primary biliary cirrhosis	0.000219	0.00692	CbGeAlD
Methotrexate—Haematuria—Colchicine—primary biliary cirrhosis	0.000217	0.00311	CcSEcCtD
Methotrexate—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000214	0.00307	CcSEcCtD
Methotrexate—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000214	0.00307	CcSEcCtD
Methotrexate—ABCC3—liver—primary biliary cirrhosis	0.000214	0.00677	CbGeAlD
Methotrexate—ABCC10—liver—primary biliary cirrhosis	0.000213	0.00673	CbGeAlD
Methotrexate—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000213	0.00305	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000213	0.00305	CcSEcCtD
Methotrexate—Agranulocytosis—Colchicine—primary biliary cirrhosis	0.000212	0.00304	CcSEcCtD
Methotrexate—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000209	0.003	CcSEcCtD
Methotrexate—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000209	0.003	CcSEcCtD
Methotrexate—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000205	0.00294	CcSEcCtD
Methotrexate—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000205	0.00294	CcSEcCtD
Methotrexate—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000204	0.00293	CcSEcCtD
Methotrexate—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000204	0.00293	CcSEcCtD
Methotrexate—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000204	0.00293	CcSEcCtD
Methotrexate—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000204	0.00293	CcSEcCtD
Methotrexate—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.000204	0.00292	CcSEcCtD
Methotrexate—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.000204	0.00292	CcSEcCtD
Methotrexate—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000201	0.00288	CcSEcCtD
Methotrexate—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000201	0.00288	CcSEcCtD
Methotrexate—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000198	0.00285	CcSEcCtD
Methotrexate—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000198	0.00285	CcSEcCtD
Methotrexate—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.000196	0.00281	CcSEcCtD
Methotrexate—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.000196	0.00281	CcSEcCtD
Methotrexate—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000195	0.00279	CcSEcCtD
Methotrexate—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000195	0.00279	CcSEcCtD
Methotrexate—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000193	0.00277	CcSEcCtD
Methotrexate—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000193	0.00277	CcSEcCtD
Methotrexate—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000193	0.00276	CcSEcCtD
Methotrexate—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000193	0.00276	CcSEcCtD
Methotrexate—Eye disorder—Colchicine—primary biliary cirrhosis	0.000191	0.00273	CcSEcCtD
Methotrexate—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000184	0.00264	CcSEcCtD
Methotrexate—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000184	0.00264	CcSEcCtD
Methotrexate—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000184	0.00264	CcSEcCtD
Methotrexate—SLCO1A2—liver—primary biliary cirrhosis	0.000183	0.0058	CbGeAlD
Methotrexate—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000183	0.00263	CcSEcCtD
Methotrexate—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000183	0.00263	CcSEcCtD
Methotrexate—ALB—liver—primary biliary cirrhosis	0.000182	0.00577	CbGeAlD
Methotrexate—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000182	0.00261	CcSEcCtD
Methotrexate—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000182	0.00261	CcSEcCtD
Methotrexate—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000181	0.0026	CcSEcCtD
Methotrexate—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000181	0.0026	CcSEcCtD
Methotrexate—Alopecia—Colchicine—primary biliary cirrhosis	0.00018	0.00258	CcSEcCtD
Methotrexate—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00018	0.00258	CcSEcCtD
Methotrexate—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00018	0.00258	CcSEcCtD
Methotrexate—Malnutrition—Colchicine—primary biliary cirrhosis	0.000178	0.00255	CcSEcCtD
Methotrexate—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000177	0.00253	CcSEcCtD
Methotrexate—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000177	0.00253	CcSEcCtD
Methotrexate—ABCC4—liver—primary biliary cirrhosis	0.000177	0.00558	CbGeAlD
Methotrexate—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00246	CcSEcCtD
Methotrexate—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00246	CcSEcCtD
Methotrexate—ABCC2—liver—primary biliary cirrhosis	0.000171	0.00541	CbGeAlD
Methotrexate—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00245	CcSEcCtD
Methotrexate—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00245	CcSEcCtD
Methotrexate—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00017	0.00244	CcSEcCtD
Methotrexate—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00017	0.00244	CcSEcCtD
Methotrexate—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000166	0.00238	CcSEcCtD
Methotrexate—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000166	0.00238	CcSEcCtD
Methotrexate—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000166	0.00237	CcSEcCtD
Methotrexate—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000166	0.00237	CcSEcCtD
Methotrexate—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000165	0.00237	CcSEcCtD
Methotrexate—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000165	0.00237	CcSEcCtD
Methotrexate—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000164	0.00236	CcSEcCtD
Methotrexate—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000164	0.00236	CcSEcCtD
Methotrexate—Anaemia—Colchicine—primary biliary cirrhosis	0.000164	0.00235	CcSEcCtD
Methotrexate—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000162	0.00232	CcSEcCtD
Methotrexate—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000162	0.00232	CcSEcCtD
Methotrexate—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00016	0.00229	CcSEcCtD
Methotrexate—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00016	0.00229	CcSEcCtD
Methotrexate—Leukopenia—Colchicine—primary biliary cirrhosis	0.000159	0.00228	CcSEcCtD
Methotrexate—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000154	0.00221	CcSEcCtD
Methotrexate—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000154	0.00221	CcSEcCtD
Methotrexate—Arthralgia—Colchicine—primary biliary cirrhosis	0.000151	0.00217	CcSEcCtD
Methotrexate—Myalgia—Colchicine—primary biliary cirrhosis	0.000151	0.00217	CcSEcCtD
Methotrexate—ABCC1—liver—primary biliary cirrhosis	0.000151	0.00476	CbGeAlD
Methotrexate—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000148	0.00212	CcSEcCtD
Methotrexate—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000148	0.00212	CcSEcCtD
Methotrexate—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000147	0.00211	CcSEcCtD
Methotrexate—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000147	0.00211	CcSEcCtD
Methotrexate—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000144	0.00206	CcSEcCtD
Methotrexate—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000144	0.00206	CcSEcCtD
Methotrexate—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000143	0.00206	CcSEcCtD
Methotrexate—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000143	0.00206	CcSEcCtD
Methotrexate—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000143	0.00205	CcSEcCtD
Methotrexate—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000143	0.00205	CcSEcCtD
Methotrexate—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000142	0.00204	CcSEcCtD
Methotrexate—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000142	0.00203	CcSEcCtD
Methotrexate—Skin disorder—Colchicine—primary biliary cirrhosis	0.000141	0.00202	CcSEcCtD
Methotrexate—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000139	0.002	CcSEcCtD
Methotrexate—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000139	0.002	CcSEcCtD
Methotrexate—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.000138	0.00198	CcSEcCtD
Methotrexate—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.000138	0.00198	CcSEcCtD
Methotrexate—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000136	0.00195	CcSEcCtD
Methotrexate—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000136	0.00195	CcSEcCtD
Methotrexate—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000136	0.00195	CcSEcCtD
Methotrexate—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000136	0.00195	CcSEcCtD
Methotrexate—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000136	0.00195	CcSEcCtD
Methotrexate—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000136	0.00195	CcSEcCtD
Methotrexate—Hypotension—Colchicine—primary biliary cirrhosis	0.000135	0.00194	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000135	0.00193	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000135	0.00193	CcSEcCtD
Methotrexate—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000134	0.00192	CcSEcCtD
Methotrexate—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000134	0.00192	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000132	0.00189	CcSEcCtD
Methotrexate—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000131	0.00188	CcSEcCtD
Methotrexate—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000131	0.00188	CcSEcCtD
Methotrexate—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000129	0.00185	CcSEcCtD
Methotrexate—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000129	0.00185	CcSEcCtD
Methotrexate—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000128	0.00183	CcSEcCtD
Methotrexate—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000128	0.00183	CcSEcCtD
Methotrexate—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000128	0.00183	CcSEcCtD
Methotrexate—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000128	0.00183	CcSEcCtD
Methotrexate—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000126	0.00181	CcSEcCtD
Methotrexate—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000126	0.00181	CcSEcCtD
Methotrexate—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000126	0.00181	CcSEcCtD
Methotrexate—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000126	0.0018	CcSEcCtD
Methotrexate—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000126	0.0018	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000125	0.00179	CcSEcCtD
Methotrexate—Fatigue—Colchicine—primary biliary cirrhosis	0.000125	0.00179	CcSEcCtD
Methotrexate—ABCG2—liver—primary biliary cirrhosis	0.000125	0.00394	CbGeAlD
Methotrexate—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000124	0.00178	CcSEcCtD
Methotrexate—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000124	0.00178	CcSEcCtD
Methotrexate—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000122	0.00174	CcSEcCtD
Methotrexate—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000122	0.00174	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000119	0.0017	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000119	0.0017	CcSEcCtD
Methotrexate—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000119	0.0017	CcSEcCtD
Methotrexate—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000118	0.00169	CcSEcCtD
Methotrexate—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000118	0.00169	CcSEcCtD
Methotrexate—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000117	0.00168	CcSEcCtD
Methotrexate—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000117	0.00168	CcSEcCtD
Methotrexate—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000116	0.00166	CcSEcCtD
Methotrexate—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000116	0.00166	CcSEcCtD
Methotrexate—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000116	0.00166	CcSEcCtD
Methotrexate—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000116	0.00166	CcSEcCtD
Methotrexate—Urticaria—Colchicine—primary biliary cirrhosis	0.000115	0.00165	CcSEcCtD
Methotrexate—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000115	0.00164	CcSEcCtD
Methotrexate—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000115	0.00164	CcSEcCtD
Methotrexate—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000115	0.00164	CcSEcCtD
Methotrexate—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000113	0.00162	CcSEcCtD
Methotrexate—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000113	0.00162	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000112	0.00161	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000112	0.00161	CcSEcCtD
Methotrexate—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000112	0.00161	CcSEcCtD
Methotrexate—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000112	0.00161	CcSEcCtD
Methotrexate—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000111	0.0016	CcSEcCtD
Methotrexate—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000111	0.0016	CcSEcCtD
Methotrexate—ABCB1—epithelium—primary biliary cirrhosis	0.000108	0.00343	CbGeAlD
Methotrexate—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000107	0.00154	CcSEcCtD
Methotrexate—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000107	0.00154	CcSEcCtD
Methotrexate—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000107	0.00153	CcSEcCtD
Methotrexate—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000106	0.00153	CcSEcCtD
Methotrexate—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000106	0.00153	CcSEcCtD
Methotrexate—Asthenia—Colchicine—primary biliary cirrhosis	0.000104	0.00149	CcSEcCtD
Methotrexate—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000103	0.00148	CcSEcCtD
Methotrexate—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000103	0.00148	CcSEcCtD
Methotrexate—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000103	0.00148	CcSEcCtD
Methotrexate—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000103	0.00148	CcSEcCtD
Methotrexate—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000103	0.00148	CcSEcCtD
Methotrexate—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000103	0.00148	CcSEcCtD
Methotrexate—Diarrhoea—Colchicine—primary biliary cirrhosis	9.92e-05	0.00142	CcSEcCtD
Methotrexate—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	9.59e-05	0.00138	CcSEcCtD
Methotrexate—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	9.59e-05	0.00138	CcSEcCtD
Methotrexate—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	9.34e-05	0.00134	CcSEcCtD
Methotrexate—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	9.34e-05	0.00134	CcSEcCtD
Methotrexate—Vomiting—Colchicine—primary biliary cirrhosis	9.22e-05	0.00132	CcSEcCtD
Methotrexate—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	9.21e-05	0.00132	CcSEcCtD
Methotrexate—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	9.21e-05	0.00132	CcSEcCtD
Methotrexate—Rash—Colchicine—primary biliary cirrhosis	9.14e-05	0.00131	CcSEcCtD
Methotrexate—Dermatitis—Colchicine—primary biliary cirrhosis	9.13e-05	0.00131	CcSEcCtD
Methotrexate—Headache—Colchicine—primary biliary cirrhosis	9.08e-05	0.0013	CcSEcCtD
Methotrexate—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	8.91e-05	0.00128	CcSEcCtD
Methotrexate—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	8.91e-05	0.00128	CcSEcCtD
Methotrexate—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	8.61e-05	0.00123	CcSEcCtD
Methotrexate—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	8.61e-05	0.00123	CcSEcCtD
Methotrexate—Nausea—Colchicine—primary biliary cirrhosis	8.61e-05	0.00123	CcSEcCtD
Methotrexate—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	8.28e-05	0.00119	CcSEcCtD
Methotrexate—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	8.28e-05	0.00119	CcSEcCtD
Methotrexate—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	8.21e-05	0.00118	CcSEcCtD
Methotrexate—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	8.21e-05	0.00118	CcSEcCtD
Methotrexate—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	8.2e-05	0.00118	CcSEcCtD
Methotrexate—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	8.2e-05	0.00118	CcSEcCtD
Methotrexate—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	8.16e-05	0.00117	CcSEcCtD
Methotrexate—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	8.16e-05	0.00117	CcSEcCtD
Methotrexate—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	7.74e-05	0.00111	CcSEcCtD
Methotrexate—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	7.74e-05	0.00111	CcSEcCtD
Methotrexate—ABCB1—liver—primary biliary cirrhosis	6.15e-05	0.00194	CbGeAlD
Methotrexate—ATIC—Metabolism—AGT—primary biliary cirrhosis	1.41e-05	0.0003	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—AGT—primary biliary cirrhosis	1.41e-05	0.0003	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.41e-05	0.000299	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—NUP210—primary biliary cirrhosis	1.4e-05	0.000299	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—OGDH—primary biliary cirrhosis	1.4e-05	0.000298	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	1.4e-05	0.000298	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PDHX—primary biliary cirrhosis	1.39e-05	0.000295	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.38e-05	0.000294	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NUP210—primary biliary cirrhosis	1.37e-05	0.000292	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.37e-05	0.000291	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.36e-05	0.00029	CbGpPWpGaD
Methotrexate—SLC22A8—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	1.35e-05	0.000287	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—OGDH—primary biliary cirrhosis	1.33e-05	0.000283	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	1.33e-05	0.000283	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—NFKB1—primary biliary cirrhosis	1.33e-05	0.000283	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	1.33e-05	0.000282	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	1.33e-05	0.000282	CbGpPWpGaD
Methotrexate—MTHFR—Disease—GOT2—primary biliary cirrhosis	1.33e-05	0.000282	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—HIF1A—primary biliary cirrhosis	1.32e-05	0.000281	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—DLAT—primary biliary cirrhosis	1.31e-05	0.000278	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ABCB4—primary biliary cirrhosis	1.31e-05	0.000278	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ABCG2—primary biliary cirrhosis	1.31e-05	0.000278	CbGpPWpGaD
Methotrexate—AOX1—Disease—GOT2—primary biliary cirrhosis	1.29e-05	0.000275	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PPARGC1A—primary biliary cirrhosis	1.29e-05	0.000275	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ABCG2—primary biliary cirrhosis	1.27e-05	0.000271	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—ALB—primary biliary cirrhosis	1.27e-05	0.000271	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.26e-05	0.000269	CbGpPWpGaD
Methotrexate—FPGS—Disease—TYK2—primary biliary cirrhosis	1.26e-05	0.000268	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PDHX—primary biliary cirrhosis	1.25e-05	0.000266	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NUP210—primary biliary cirrhosis	1.25e-05	0.000265	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—OGDH—primary biliary cirrhosis	1.23e-05	0.000262	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.23e-05	0.000261	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—NOS2—primary biliary cirrhosis	1.21e-05	0.000257	CbGpPWpGaD
Methotrexate—PGD—Disease—HIF1A—primary biliary cirrhosis	1.21e-05	0.000257	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.2e-05	0.000256	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.2e-05	0.000256	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NOS2—primary biliary cirrhosis	1.2e-05	0.000255	CbGpPWpGaD
Methotrexate—SLCO1A2—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	1.2e-05	0.000254	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PDHX—primary biliary cirrhosis	1.19e-05	0.000253	CbGpPWpGaD
Methotrexate—DHFR—Disease—GOT2—primary biliary cirrhosis	1.18e-05	0.00025	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—DLAT—primary biliary cirrhosis	1.17e-05	0.00025	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ABCB4—primary biliary cirrhosis	1.17e-05	0.00025	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CD80—primary biliary cirrhosis	1.16e-05	0.000248	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ABCG2—primary biliary cirrhosis	1.16e-05	0.000247	CbGpPWpGaD
Methotrexate—MTHFR—Disease—GOT1—primary biliary cirrhosis	1.14e-05	0.000243	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NUP210—primary biliary cirrhosis	1.14e-05	0.000242	CbGpPWpGaD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	1.12e-05	0.000239	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CTGF—primary biliary cirrhosis	1.12e-05	0.000238	CbGpPWpGaD
Methotrexate—AOX1—Disease—GOT1—primary biliary cirrhosis	1.12e-05	0.000238	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—DLAT—primary biliary cirrhosis	1.12e-05	0.000237	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ABCB4—primary biliary cirrhosis	1.12e-05	0.000237	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GOT2—primary biliary cirrhosis	1.11e-05	0.000236	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—AGT—primary biliary cirrhosis	1.1e-05	0.000234	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PDHX—primary biliary cirrhosis	1.1e-05	0.000234	CbGpPWpGaD
Methotrexate—PGD—Disease—NOS2—primary biliary cirrhosis	1.1e-05	0.000233	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CTGF—primary biliary cirrhosis	1.09e-05	0.000233	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NUP210—primary biliary cirrhosis	1.09e-05	0.000232	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GOT2—primary biliary cirrhosis	1.08e-05	0.000231	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—ALB—primary biliary cirrhosis	1.08e-05	0.000231	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—ALB—primary biliary cirrhosis	1.08e-05	0.000231	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.08e-05	0.00023	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.07e-05	0.000228	CbGpPWpGaD
Methotrexate—PGD—Disease—CD80—primary biliary cirrhosis	1.06e-05	0.000226	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.06e-05	0.000226	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ABCG2—primary biliary cirrhosis	1.06e-05	0.000225	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	1.06e-05	0.000225	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LBR—primary biliary cirrhosis	1.05e-05	0.000224	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ABCB4—primary biliary cirrhosis	1.03e-05	0.00022	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—DLAT—primary biliary cirrhosis	1.03e-05	0.00022	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.03e-05	0.000219	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	1.02e-05	0.000218	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—ALB—primary biliary cirrhosis	1.02e-05	0.000216	CbGpPWpGaD
Methotrexate—DHFR—Disease—GOT1—primary biliary cirrhosis	1.02e-05	0.000216	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ABCG2—primary biliary cirrhosis	1.01e-05	0.000215	CbGpPWpGaD
Methotrexate—PGD—Metabolism—AGT—primary biliary cirrhosis	1.01e-05	0.000214	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NUP210—primary biliary cirrhosis	9.99e-06	0.000212	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CTGF—primary biliary cirrhosis	9.95e-06	0.000212	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GOT2—primary biliary cirrhosis	9.86e-06	0.00021	CbGpPWpGaD
Methotrexate—ABCC1—Disease—ELMO1—primary biliary cirrhosis	9.84e-06	0.000209	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—TYK2—primary biliary cirrhosis	9.83e-06	0.000209	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	9.63e-06	0.000205	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GGT1—primary biliary cirrhosis	9.58e-06	0.000204	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GOT1—primary biliary cirrhosis	9.58e-06	0.000204	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	9.57e-06	0.000204	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GOT1—primary biliary cirrhosis	9.36e-06	0.000199	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GGT1—primary biliary cirrhosis	9.36e-06	0.000199	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	9.33e-06	0.000199	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ABCG2—primary biliary cirrhosis	9.28e-06	0.000197	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LBR—primary biliary cirrhosis	9.22e-06	0.000196	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	9.15e-06	0.000195	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CTGF—primary biliary cirrhosis	9.06e-06	0.000193	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS2—primary biliary cirrhosis	9.02e-06	0.000192	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NUP210—primary biliary cirrhosis	9.01e-06	0.000192	CbGpPWpGaD
Methotrexate—PGD—Disease—TYK2—primary biliary cirrhosis	8.99e-06	0.000191	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GOT2—primary biliary cirrhosis	8.98e-06	0.000191	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	8.98e-06	0.000191	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	8.95e-06	0.00019	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	8.8e-06	0.000187	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CTGF—primary biliary cirrhosis	8.68e-06	0.000185	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GOT2—primary biliary cirrhosis	8.6e-06	0.000183	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PPARGC1A—primary biliary cirrhosis	8.52e-06	0.000181	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GOT1—primary biliary cirrhosis	8.51e-06	0.000181	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GGT1—primary biliary cirrhosis	8.51e-06	0.000181	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—ALB—primary biliary cirrhosis	8.44e-06	0.00018	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NUP210—primary biliary cirrhosis	8.43e-06	0.000179	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ABCG2—primary biliary cirrhosis	8.38e-06	0.000178	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	8.33e-06	0.000177	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PPARGC1A—primary biliary cirrhosis	8.33e-06	0.000177	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	8.18e-06	0.000174	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	8.18e-06	0.000174	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	8.15e-06	0.000173	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	8.14e-06	0.000173	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CTGF—primary biliary cirrhosis	7.96e-06	0.000169	CbGpPWpGaD
Methotrexate—MTHFR—Disease—HIF1A—primary biliary cirrhosis	7.96e-06	0.000169	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GOT2—primary biliary cirrhosis	7.89e-06	0.000168	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NUP210—primary biliary cirrhosis	7.85e-06	0.000167	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	7.84e-06	0.000167	CbGpPWpGaD
Methotrexate—AOX1—Disease—HIF1A—primary biliary cirrhosis	7.77e-06	0.000165	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GGT1—primary biliary cirrhosis	7.75e-06	0.000165	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GOT1—primary biliary cirrhosis	7.75e-06	0.000165	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	7.74e-06	0.000165	CbGpPWpGaD
Methotrexate—PGD—Metabolism—ALB—primary biliary cirrhosis	7.72e-06	0.000164	CbGpPWpGaD
Methotrexate—ALB—Metabolism—OGDH—primary biliary cirrhosis	7.61e-06	0.000162	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	7.61e-06	0.000162	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—ALB—primary biliary cirrhosis	7.58e-06	0.000161	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PPARGC1A—primary biliary cirrhosis	7.58e-06	0.000161	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	7.5e-06	0.000159	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GGT1—primary biliary cirrhosis	7.43e-06	0.000158	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GOT1—primary biliary cirrhosis	7.43e-06	0.000158	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	7.34e-06	0.000156	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ABCG2—primary biliary cirrhosis	7.29e-06	0.000155	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS2—primary biliary cirrhosis	7.24e-06	0.000154	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CTGF—primary biliary cirrhosis	7.19e-06	0.000153	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	7.17e-06	0.000153	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	7.13e-06	0.000152	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GOT2—primary biliary cirrhosis	7.12e-06	0.000151	CbGpPWpGaD
Methotrexate—DHFR—Disease—HIF1A—primary biliary cirrhosis	7.07e-06	0.00015	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS2—primary biliary cirrhosis	7.07e-06	0.00015	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NUP210—primary biliary cirrhosis	7.06e-06	0.00015	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD80—primary biliary cirrhosis	7.02e-06	0.000149	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	6.98e-06	0.000149	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PPARGC1A—primary biliary cirrhosis	6.9e-06	0.000147	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	6.87e-06	0.000146	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD80—primary biliary cirrhosis	6.86e-06	0.000146	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	6.85e-06	0.000146	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GGT1—primary biliary cirrhosis	6.81e-06	0.000145	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GOT1—primary biliary cirrhosis	6.81e-06	0.000145	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PDHX—primary biliary cirrhosis	6.78e-06	0.000144	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NUP210—primary biliary cirrhosis	6.71e-06	0.000143	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	6.67e-06	0.000142	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	6.67e-06	0.000142	CbGpPWpGaD
Methotrexate—ABCC1—Disease—GOT2—primary biliary cirrhosis	6.66e-06	0.000142	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—AGT—primary biliary cirrhosis	6.64e-06	0.000141	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PPARGC1A—primary biliary cirrhosis	6.61e-06	0.000141	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	6.56e-06	0.00014	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ABCG2—primary biliary cirrhosis	6.56e-06	0.00014	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—AGT—primary biliary cirrhosis	6.49e-06	0.000138	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS2—primary biliary cirrhosis	6.43e-06	0.000137	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	6.39e-06	0.000136	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCB4—primary biliary cirrhosis	6.38e-06	0.000136	CbGpPWpGaD
Methotrexate—ALB—Metabolism—DLAT—primary biliary cirrhosis	6.38e-06	0.000136	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CTGF—primary biliary cirrhosis	6.26e-06	0.000133	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD80—primary biliary cirrhosis	6.24e-06	0.000133	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ABCG2—primary biliary cirrhosis	6.24e-06	0.000133	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NUP210—primary biliary cirrhosis	6.21e-06	0.000132	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GOT2—primary biliary cirrhosis	6.2e-06	0.000132	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GOT1—primary biliary cirrhosis	6.15e-06	0.000131	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GGT1—primary biliary cirrhosis	6.15e-06	0.000131	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	6.08e-06	0.000129	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PPARGC1A—primary biliary cirrhosis	6.06e-06	0.000129	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	5.94e-06	0.000126	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TYK2—primary biliary cirrhosis	5.93e-06	0.000126	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—AGT—primary biliary cirrhosis	5.9e-06	0.000125	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	5.87e-06	0.000125	CbGpPWpGaD
Methotrexate—AOX1—Disease—TYK2—primary biliary cirrhosis	5.79e-06	0.000123	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	5.75e-06	0.000122	CbGpPWpGaD
Methotrexate—ABCC1—Disease—GOT1—primary biliary cirrhosis	5.75e-06	0.000122	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	5.71e-06	0.000122	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CTGF—primary biliary cirrhosis	5.63e-06	0.00012	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	5.59e-06	0.000119	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	5.59e-06	0.000119	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GOT2—primary biliary cirrhosis	5.58e-06	0.000119	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	5.54e-06	0.000118	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PPARGC1A—primary biliary cirrhosis	5.47e-06	0.000116	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	5.47e-06	0.000116	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	5.47e-06	0.000116	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—AGT—primary biliary cirrhosis	5.37e-06	0.000114	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GGT1—primary biliary cirrhosis	5.35e-06	0.000114	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GOT1—primary biliary cirrhosis	5.35e-06	0.000114	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CTGF—primary biliary cirrhosis	5.35e-06	0.000114	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GOT2—primary biliary cirrhosis	5.3e-06	0.000113	CbGpPWpGaD
Methotrexate—DHFR—Disease—TYK2—primary biliary cirrhosis	5.27e-06	0.000112	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	5.23e-06	0.000111	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	5.2e-06	0.000111	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—AGT—primary biliary cirrhosis	5.15e-06	0.00011	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ALB—primary biliary cirrhosis	5.1e-06	0.000108	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	4.98e-06	0.000106	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ALB—primary biliary cirrhosis	4.98e-06	0.000106	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CTGF—primary biliary cirrhosis	4.96e-06	0.000105	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GOT2—primary biliary cirrhosis	4.91e-06	0.000104	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GOT1—primary biliary cirrhosis	4.82e-06	0.000102	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GGT1—primary biliary cirrhosis	4.82e-06	0.000102	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	4.81e-06	0.000102	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	4.76e-06	0.000101	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—AGT—primary biliary cirrhosis	4.72e-06	0.0001	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GOT1—primary biliary cirrhosis	4.58e-06	9.74e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GGT1—primary biliary cirrhosis	4.58e-06	9.74e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ALB—primary biliary cirrhosis	4.53e-06	9.63e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARGC1A—primary biliary cirrhosis	4.29e-06	9.12e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—AGT—primary biliary cirrhosis	4.26e-06	9.06e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GGT1—primary biliary cirrhosis	4.24e-06	9.02e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GOT1—primary biliary cirrhosis	4.24e-06	9.02e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ALB—primary biliary cirrhosis	4.12e-06	8.77e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS2—primary biliary cirrhosis	4.08e-06	8.68e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARGC1A—primary biliary cirrhosis	4.07e-06	8.67e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	4.07e-06	8.66e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HIF1A—primary biliary cirrhosis	4e-06	8.51e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ALB—primary biliary cirrhosis	3.95e-06	8.4e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NUP210—primary biliary cirrhosis	3.83e-06	8.15e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARGC1A—primary biliary cirrhosis	3.77e-06	8.02e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—AGT—primary biliary cirrhosis	3.71e-06	7.89e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS2—primary biliary cirrhosis	3.64e-06	7.74e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ALB—primary biliary cirrhosis	3.62e-06	7.71e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCG2—primary biliary cirrhosis	3.56e-06	7.58e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD80—primary biliary cirrhosis	3.53e-06	7.51e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	3.36e-06	7.14e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—AGT—primary biliary cirrhosis	3.34e-06	7.1e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALB—primary biliary cirrhosis	3.27e-06	6.96e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—AGT—primary biliary cirrhosis	3.17e-06	6.75e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	3.12e-06	6.64e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CTGF—primary biliary cirrhosis	3.06e-06	6.5e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GOT2—primary biliary cirrhosis	3.03e-06	6.45e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TYK2—primary biliary cirrhosis	2.98e-06	6.34e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—AGT—primary biliary cirrhosis	2.94e-06	6.25e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALB—primary biliary cirrhosis	2.85e-06	6.06e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	2.68e-06	5.7e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	2.66e-06	5.65e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GGT1—primary biliary cirrhosis	2.62e-06	5.56e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GOT1—primary biliary cirrhosis	2.62e-06	5.56e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.6e-06	5.54e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALB—primary biliary cirrhosis	2.56e-06	5.45e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALB—primary biliary cirrhosis	2.44e-06	5.18e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARGC1A—primary biliary cirrhosis	2.33e-06	4.95e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	2.29e-06	4.87e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	2.29e-06	4.87e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALB—primary biliary cirrhosis	2.25e-06	4.8e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	2.04e-06	4.34e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AGT—primary biliary cirrhosis	1.81e-06	3.86e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AGT—primary biliary cirrhosis	1.59e-06	3.38e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALB—primary biliary cirrhosis	1.22e-06	2.59e-05	CbGpPWpGaD
